ArticleCancer pathogenesis and therapy2024

Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment: A phase 2 clinical trial (BG01-1801).

Yuankai Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.